Newsroom
Sorted by: Latest
-
Sapphire BLU and Fiducia | AI Advance Cognitive Visual Recognition (CVR) Capabilities for Defense and National Security Applications
LAS VEGAS--(BUSINESS WIRE)--Sapphire BLU, in partnership with Fiducia | AI, an IBM Silver Partner specializing in advanced artificial intelligence and edge computing solutions, is pleased to announce that its Cognitive Visual Recognition (CVR) solution has received positive feedback during recent government and industry engagement activities. The CVR solution has generated significant interest for its ability to rapidly analyze and transform large volumes of structured, unstructured, and visual...
-
Algolia Study: AI — The Key to Personalized Shopping Experiences
BERLIN--(BUSINESS WIRE)--Artificial intelligence (AI) has the potential to fundamentally transform online shopping. Germans are increasingly convinced that the growing adoption of AI is leading to better shopping experiences. This is the key finding of a representative study conducted by Algolia among 1,000 German consumers in June 2026. According to the survey, consumers increasingly view AI as the key to more relevant, convenient, and personalized shopping experiences. “Today’s consumers expe...
-
SFL Missions Inc. Begins Phase A Study for ESA Moonraker Lunar Mapping Project
TORONTO--(BUSINESS WIRE)--SFL Missions Inc. is a member of the team led by Prime Contractor NUVIEW GmbH selected by the European Space Agency (ESA) to conduct the Moonraker Phase A study. SFL Missions is the spacecraft team member responsible for developing the small satellite platform that will host the laser scanning (LiDAR) payload. SFL is also performing mission analysis and planning for launch and operations of the Moonraker spacecraft.Following completion of a successful Pre-Phase A study...
-
Palantir and Zeta Global Announce Strategic Partnership to Build a Unified Data and AI Infrastructure for the Future of Marketing, with Athena by Zeta™ at the Center
MIAMI & NEW YORK--(BUSINESS WIRE)--Palantir and Zeta Global Announce Strategic Partnership to Build a Unified Data and AI Infrastructure for the Future of Marketing...
-
Genetix Biotherapeutics and SPIMACO Announce Strategic Agreement to Commercialize and Manufacture LYFGENIA™ & ZYNTEGLO™ in Saudi Arabia and the Broader Middle East Region
SOMERVILLE, Mass.--(BUSINESS WIRE)--Genetix Biotherapeutics Inc. and the Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) and its wholly owned subsidiary, SPIMACO Bio, today announced an exclusive collaboration and license agreement for the development, commercialization, and localized manufacturing of LYFGENIA™ and ZYNTEGLO™ in Saudi Arabia and across the broader Middle East. LYFGENIA and ZYNTEGLO are first-in-class, one-time gene addition cell therapies for the tre...
-
Headwater Science Names Susan Barnes Head of Operations
DURHAM, N.C.--(BUSINESS WIRE)--Headwater Science, a leading data science and methods company, today announced the appointment of Susan Barnes, Ph.D., as head of operations. In this role, Dr. Barnes will oversee the company's operations and organizational performance as Headwater Science continues to expand its capabilities and impact across the healthcare ecosystem.Barnes joins Headwater Science following senior leadership roles leading large-scale transformation initiatives and enterprise growt...
-
Amylyx Pharmaceuticals to Present Data from First-in-Human, Dose-Ranging Phase 1 LUMINA Trial of AMX0114 in ALS at ENCALS 2026
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals to Present Data from First-in-Human, Dose-Ranging Phase 1 LUMINA Trial of AMX0114 in ALS at ENCALS 2026...
-
NationsBenefits Redefines Access Through National Expansion of Integrated Wellness, OTC, and Nutrition Benefits
PLANTATION, Fla.--(BUSINESS WIRE)--Eligible health plan members can now use the NationsBenefits® Flex Card at Sam’s Club to simplify grocery, OTC, and health and wellness purchases....
-
Syntax Bio and Applied StemCell Announce Strategic Collaboration to Advance Stem Cell Innovation
CHICAGO & MILPITAS, Calif.--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Applied StemCell Corp. (ASC), a leader in induced pluripotent stem cell (iPSC) technology and genome engineering, today announced a strategic collaboration to help unlock the next generation of regenerative medicine. The collaboration will focus on evaluating ASC’s iPSC and hypoimmune cell lines using Syntax Bio’s proprietary Cellgorithm™ platform to advanc...
-
ABBYY Releases FineReader Engine with DocLang, the AI Native Document Standard
AUSTIN, Texas--(BUSINESS WIRE)--ABBYY FineReader Engine now supports DocLang, the AI-native standard for document structure....